US OptionsDetailed Quotes
SGMO250117C500
- 0.55
- -0.04-6.78%
15min DelayClose Jan 17 16:00 ET
0.63High0.55Low
0.63Open0.59Pre Close62 Volume121 Open Interest0.50Strike Price3.46KTurnover0.00%IV-3.67%PremiumJan 17, 2025Expiry Date0.59Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.08Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Sangamo Therapeutics Stock Discussion
Sign in to post a comment
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway | 4D Molecular Therapeutics
1
1
$Sangamo Therapeutics (SGMO.US)$ lets go~~~~up
The trading year ended with markets declining
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
Shortly after close, the $S&P 500 Index (.SPX.US)$ dipped 0.43% to 5,881.63, the $Dow Jones Industrial Average (.DJI.US)$ edged down 0.07% to 42,544.22, and the $Nasdaq Composite Index (.IXIC.US)$ dropped 0.9% to 19,310.79.
For the year, the Nasdaq Composite led the way, rising 29%. The S&P 500 was up 23% (a second straight year of 20% gains) and the Dow added almost 13%.
MACR...
63
6
8
Barclay's keeps overweight and maintains 9 dollar target. Says they assigned limited value to the Hemo A program. Very Intresting
4
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. No buy pressure/momentum- No day t...
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Scale out and secure profits. GREED will make losr and get trapped.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 CH (cash on hand); AH (after hours): RTH (regular trading hours)
7. No buy pressure/momentum- No day t...
74
23
9
$Sangamo Therapeutics (SGMO.US)$ buy buy buy
3
1
No comment yet
BigAlMoney : Sangamo's Fabry results are much better. We have Accelerated Approval Pathway from FDA recently. Gets a drug to market 3 years sooner. No expensive Phase 3 required. Existing cohorts just monitored by eGFR, 5 dollar lab test. BLA can be filed thus year. In discussions with several big Pharma for buyout or Partnership.